NuGen Medical Devices Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was CAD 0.115819 million compared to CAD 0.004028 million a year ago. Net loss was CAD 2.28 million compared to CAD 1.19 million a year ago. Basic loss per share from continuing operations was CAD 0.012 compared to CAD 0.014 a year ago.
For the nine months, sales was CAD 0.162744 million compared to CAD 0.130394 million a year ago. Net loss was CAD 6.79 million compared to CAD 3.83 million a year ago. Basic loss per share from continuing operations was CAD 0.042 compared to CAD 0.043 a year ago.